drug

nivolumab biosimilar

Phase 3updated 3mo ago

by Xbrane Biopharma AB

Phase 3

community read0 votes

indications

NSCLCMelanoma

all catalysts(0)

nothing on the calendar yet

Trials studying nivolumab biosimilar

phase3Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanomarecruitingn=632

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 8m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

nivolumab biosimilar

Phase 3updated 3mo ago

by Xbrane Biopharma AB

Phase 3

community read0 votes

indications

NSCLCMelanoma

all catalysts(0)

nothing on the calendar yet

Trials studying nivolumab biosimilar

phase3Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanomarecruitingn=632

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 8m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

nivolumab biosimilar

indications

all catalysts(0)

Trials studying nivolumab biosimilar

News(0)

Report a data issue

comments(0)

nivolumab biosimilar

indications

all catalysts(0)

Trials studying nivolumab biosimilar

News(0)

Report a data issue

comments(0)